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ABSTRACT 
Natural killer (NK) cells are innate immune cells that mount responses against virally infected, 
transformed and allogeneic transplanted cells. Equipped with cytolytic molecules and death receptors, 
NK cells mediate cytotoxicity against cells expressing low levels of MHC class I (MHC-I) or high 
levels of stress-induced molecules. NK cells are also immune-modulatory, releasing various 
cytokines and chemokines as well as kill immature immune cells. A tight regulation is available to 
endow NK cells with capacity to distinguish self and non-self, while making sure that they are well 
functional. Numerous extrinsic and intrinsic factors become parts of the regulatory network to control 
NK cell development, maturation and functional acquisition.  
Interleukin 15 (IL-15) is an indispensable cytokine throughout NK cell biology. In this thesis, a few 
novel aspects of IL-15 in NK cell biology under non-inflammatory conditions were reported. In paper 
I, the importance of IL-15 expressed by dendritic cells (DCs) for NK cell homeostasis, maturation, 
and functions at steady-state were investigated. In paper II, the coordination of IL-15 with activating 
signaling DNAX-1-associated receptor (DNAM-1) in controlling the expression of linker for 
activation of T cells (LAT), an activating signaling molecule, was studied. In paper III, we studied 
the functional impact of brief contact with IL-15 (“priming”) and its underlying molecular 
mechanism. Finally, in paper IV, the roles of forkhead box transcription factors of the O class 
(FOXO) transcription factors in NK cell development in relation to IL-15 receptor (IL-15R) 
expression and other transcription factors were explored (Figure 1).  
In summary, we have found that under non-inflammatory conditions, the presence of DCs is required 
to maintain NK cell homeostasis in regards to apoptosis and proliferation. NK cell maturation and 
receptor expression were also perturbed upon DC depletion. Importantly, DC derived IL-15 was 
required for “missing self” reactivity of NK cells in the absence of infection (paper I). At steady-
state, the brief contacts with IL-15 are functionally relevant as five-minute treatment with IL-15 
augmented degranulation, cytokine production, and calcium flux triggered by activating receptor 
stimulation, as well as cytotoxicity against YAC1 cells (paper III). Short-time IL-15 stimulation 
induced phosphorylation of activating signaling molecules, which is Janus Kinase 3 (JAK3) 
dependent. The functional impact of short time IL-15 stimulation remained up to three hours after IL-
15 removal. In paper II, IL-15 stimulation was found to induce expression of LAT especially in 
DNAM-1+ NK cells. The absence of DNAM-1 or its ligand, CD155, reduced LAT expression. The 
heightened level of LAT expression in DNAM-1+ NK cells endows them with better responsiveness 
to NK1.1 stimulation, as measured by calcium flux, cytokine production and degranulation.  
In the last paper, paper IV, mouse models with specific deletion of FOXO1 and FOXO3 in 
hematopoietic cells (Vav1+iCre FOXO1,3flox/flox) were employed to study the roles of these 
transcription factors in NK cell development. Upon depletion of FOXO1,3 in Vav1+ cells, NK cell 
development was blocked at the transition from pre-NK cell progenitors (preNKP) (CD122- or IL-
15Rβ-) to refined NK cell progenitors (rNKP) (CD122+), resulting in very few committed NK cells 
in both bone marrow (BM) and spleen. The few NK cells developing in the absence of FOXO1,3 
were less mature and display perturbed inhibitory and activating receptor expression. The 
transplantation experiment demonstrated that the effects of FOXO1,3 on NK cell development, 
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maturation and receptor expression were NK-cell-progenitor intrinsic. The experiment employing 
RNA sequencing (RNA-seq) and assay for transposase-accessible chromatin using sequencing 
(ATAC-seq) revealed a possible mechanism underlying the roles of FOXO1,3 in controlling NK cell 
development. The expression and/or DNA binding of ETS proto-oncogene 1 (ETS1), transcription 
factor T cell factor 7 (TCF7), and CD122 were affected in different stages of NK cell development 
in the absence of FOXO1,3. With the reduction in CD122 (IL-15Rβ), mature NK cells from both BM 
and spleen displayed an increase rate in undergoing apoptosis. Taken together, FOXO1,3 controlled 
IL-15R expression on NK progenitors and committed NK cells, which contributes to maintain NK 
cell population in mice.  
In summary, we have found that, under non-inflammatory condition, IL-15 regulated NK cell 
homeostasis and functions, brief contacts with IL-15 were functionally relevant, and the cellular effect 
was coordinated with DNAM-1 signaling via controlling LAT expression. Lastly, FOXO1,3 were 
identified as novel transcription factors which control IL-15R expression and NK cell development.
 
Figure 1. Summary of the work in this thesis. Murine NK cells develop from common 
lymphoid progenitors (CLP) which downregulate FLT3 to become preNKP. PreNKP acquire IL-
15Rβ (CD122) to become rNKP, which subsequently express activating and inhibitory receptors 
to become immature NK cells. Immature NK cells express adhesion molecules, migrate to the 
periphery and acquire functional education. IL-15 plays a crucial role throughout NK cell biology 
including formation of NKP, expression of signaling molecules (LAT), survival, proliferation and 
maturation. FLT3: fms like tyrosine kinase 3, Ncr1: natural cell receptor 1.  
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1 INTRODUCTION 
 OVERVIEW OF NATURAL KILLER CELLS 
Natural killer (NK) cells were first identified as a subset of large granular lymphocytes that exert non-
specific cytotoxicity against various solid tumors and hematopoietic malignancies [1-3]. This 
lymphocyte subset was named NK cells owing to their capacity to exert “natural” cytotoxicity without 
a prior activation [4, 5]. NK cells are important not only for their cytotoxicity but also for being major 
players in the immune regulatory network, by producing a wide range of cytokines and chemokines, 
including IL-1β, chemokine (C-X-C motif) ligand 1 (CXCL8 or IL-8), tumor necrosis factor α (TNF-
α), IL-10, IL-13, granulocyte macrophage colony stimulating factor (GM-CSF), interferon α (IFN-
α), interferon γ (IFN-γ), transforming growth factor β (TGF-β), chemokine (C-C motif) ligand 3 and 
4 (CCL3, CCL4) [6-10]. NK cell immune-modulatory effects were also attributed to their capacity to 
exert cytotoxicity towards other immune cells, including T, B, and dendritic cells (DCs) [11-14]. NK 
cells were recently showed to also regulate certain bacterial or fungal infections [7]. 
NK cells were originally distinguished from T cell cytotoxic lymphocytes due to their lack of receptor 
specificity based on genetic recombination (such as the B cell receptor and T cell receptor), their 
quick response without a need for sensitization, and their lack of a recall or memory response. This 
distinction has been challenged recently by numerous studies showing that NK cells indeed possess 
characteristics that were attributed to adaptive cells. Firstly, NK cells do need constant signals from 
accessory cells, namely macrophages, neutrophils, and DCs for their optimal functions. These cells 
provide both contact-dependent and independent signals to NK cells and reside in close areas with 
NK cells in the secondary lymphoid tissues. Secondly, some human NK cell inhibitory receptors can 
be highly polymorphic and display differential binding affinities to different human leukocyte antigen 
class I (HLA-I) groups and HLA-I ligands. The specificity is decided at the level of single amino acid 
substitution, creating numerous combinations of NK receptor-HLA-I pairs [15]. Even though the 
receptor pool is much more limited and not based on DNA recombination, such as in T and B cells, 
the degree of specificity is beyond what would be expected of an innate cell type. Lastly, upon certain 
viral infections, including cytomegalovirus (CMV), vaccinia virus, herpes simplex virus type 2, 
human immunodeficiency virus (HIV) and influenza, NK cells form a long-lived memory population 
which is capable of mounting a strong recall response [10, 16, 17].  
In some reports, NK cells were classified to group 1 ILC together with ILC1. ILC, which include 
ILC1, ILC2, ILC3 and lymphoid tissue inducers (LTi), are the innate counterparts of T lymphocytes 
and are mostly tissue residents. They play a crucial role in maintaining tissue homeostasis, mainly in 
the intestine, adipose tissue and lung. NK cells are closely related to ILC1 in their capacity to produce 
IFN-γ. In mice, NK cells are circulating and dependent on eomesodermin (EOMES) while ILC1 are 
tissue residents and dependent on T-box protein expressed in T cells (T-BET) [18, 19]. NK cells are 
more cytotoxic and express higher levels of perforin than ILC1 [20]. ILC2 produce IL-4, IL-5, IL-13, 
and ligands for epithelial growth factor receptors, such as AREG, and are important for the control of 
large extracellular pathogens, i.e. helminths, and tissue repair [20]. ILC2 development is dependent 
on GATA3 and RAR-related orphan receptor alpha (RORα) [21]. ILC3 secrete IL-22 and IL-17 to 
control extracellular microbes and regulate tissue remodeling and their development depends on 
RORC [20]. LTi play a major role for lymphoid organ homeostasis by modulating the capacity of 
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mesenchymal stromal cells to release chemokines and adhesion molecules which are important for 
lymphoid organogensis  [22]. 
 NK CELL RECEPTORS  
 NK cell receptors and signaling 
NK cells possess the potent cytotoxicity; and hence, it is crucial that a well-regulated mechanism 
would be developed to modulate their functions. The regulation is the integration of  signals from two 
types of surface receptors, activating and inhibitory receptors [23]. These receptors are expressed in 
a stochastic and variegated pattern on NK cells, which results in the formation of subsets expressing 
different receptors and likely having distinct functions. Unlike T and B cells, NK cell receptors are 
germline-encoded, recognize a limited set of ligands and do not form based on the DNA 
rearrangement process. Likewise, NK cell self-tolerance is not dependent on the selective 
survivability of developing cells, but shaped via the counterbalancing between the reactive and 
inhibitory signals [24].  
Activating receptors recognize ligands upregulated on transformed, stressed, or viral-infected cells 
[25, 26]. Some activating receptors also recognize constitutively expressed ligands on healthy cells, 
such as the mouse MHC-I molecule H2-Dd, which is recognized by an activating receptor – Ly49D. 
In mice, the most studied activating receptors are natural cytotoxicity receptors (NKp46), the Fcγ 
receptor IIIA (CD16), DNAM-1, NKG2D, C-type lectin-like Ly49 receptors (Ly49D, Ly49H), and 
signaling leukocyte activating molecule (SLAM) family receptors [27]. Activating receptors 
normally do not signal by themselves, but associate with adaptor molecules bearing immunoreceptor 
tyrosine-based activating motifs (ITAM), such as DNAX activating protein of 12 kDa (DAP12), 
FcεRIγ and CD3ζ [28]. Signaling through some receptors is ITAM-independent such as DNAM-1 
and Ly49H [29, 30]. Following activation through ligand binding or receptor crosslinking by 
monoclonal antibodies, Sarcoma kinase (SRC) family members phosphorylate ITAMs, which then 
serve as the binding sites for Src2 homology 2 (SH2) of zeta-chain-associated protein kinase 70 
(ZAP70) and SYK tyrosine kinases. Activated ZAP70/SYK phosphorylates LAT and SH2 domain-
containing leukocyte phosphoprotein of 76kDa (SLP-76), which act as plasma membrane bound 
adaptor molecules. These adaptors recruit downstream signaling molecules and activate signaling 
cascades through Vav1, phosphoinositide phospholipase C-γ2 (PLC-γ2) or adhesion and 
degranulation- promoting adapter protein (ADAP), finally resulting in degranulation and 
transcriptional upregulation of immune regulators [31]. In detail, PLC-γ2 facilitates the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) to become inositol 1,4,5-trisphosphate (IP3) and diacyl 
glycerol (DAG). IP3 binds to calcium channels on the endoplasmic reticulum (ER) which facilitates 
the release of Ca2+ ions into the cytoplasm. The released Ca2+ acts on calcium-sensitive proteins like 
calmodulin to mediate actin cytoskeletal remodeling. The process is facilitated by Vav1, which 
activates the small GTPase, including Rho and Rac. DAG and Ca2+-sensitive molecules activates 
mitogen-activated protein kinase (MAPK) pathways or protein kinase C θ (PKC-θ) that induce the 
transcription of effector molecules, including granzyme B, perforin, IFN-γ, TNF-α [32].  
Inhibitory receptors recognize MHC-I molecules or non-classical MHC-I molecules (Qa-1(b), H2M3) 
expressed by healthy cells, counteracting activating signals and serving as “do not kill me” signals to 
prevent self-damage to endogenous tissue [33, 34]. In mice, most prevalent inhibitory receptors are 
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C-type lectin receptors, including Ly49 receptors (Ly49C, LY49I, Ly49A, Ly49G2, Ly49F) and 
CD94/NKG2A [27]. Transformed cells and virus infected cells with downregulated MHC-I 
expression or transplanted/grafted cells expressing mismatched MHC- I can induce a ‘missing self’ 
recognition by NK cells [35-37]. Binding of inhibitory receptors to MHC-I leads to activation of Src-
family tyrosine kinases, such as lymphocyte-specific protein tyrosine kinase (LCK). Src kinases 
phosphorylate tyrosine-based inhibitory motifs (ITIMs) on the intracellular domains of inhibitory 
receptors. The phosphorylated sites will serve as docking motives for Src homology 2 (SH2)-domain-
containing phosphatases (SHP-1 or SHP-2), which directly dephosphorylate Vav1 [38]. Besides 
signaling through phosphatases, stimulation through inhibitory receptors induces phosphorylation of 
CRK tyrosine adaptor, dissociating it from the complex with the scaffold protein Casitas B-lineage 
Lymphoma (c-CBL) and guanine exchange protein C3G [39, 40].  
 Mechanism of NK cell killing 
Upon being activated and encounter with a target cell with an increased expression of activating 
ligands or a decrease in MHC-I expression, NK cells form an immunological synapse (IS) with target 
cells via which cytotoxic mediators are released. The cytotoxic mediators are packed in cytolytic 
granules which are polarized towards IS along the microtubules. Main cytotoxic mediators in NK 
cells are perforins, granzymes, granulysin, fas ligand (FASL), TNF-related apoptosis-inducing ligand 
(TRAIL) [41-43]. The mediators induce target cell death via two main molecular mechanisms. 
The first mechanism involves perforins and granzymes. Granzymes are delivered to target cells via 
pores on their membrane formed by perforin molecules [43]. Target cell apoptosis is then induced via 
caspase-dependent or independent mechanisms which involve activation of a pro-apoptotic molecule, 
BH3 interacting-domain death agonist (BID), directly acting on the mitochondrial membrane and 
inducing cytochrome C release [44, 45]. Another killing mechanism involves death receptors 
including the TNF-related apoptosis-inducing ligand (TRAIL) receptor and FAS, being activated by 
cognate ligands on NK cells, namely TRAIL and fas ligand (FASL) [46]. The engagement of 
corresponding ligand-receptors induces target cell apoptosis via an extrinsic apoptotic pathway [47]. 
The extrinsic apoptotic pathway involves cytoplasmic death domain, capase-8, capase-10, and finally 
caspase-3, which mediates the release of cytochrome C from mitochondria and hence the formation 
of an apoptosome. Capase-3 induces DNA fragmentation [48] and the apoptosome enhances the 
cleavage of caspase-3 mediated by capase-8 and -10 [49], resulting in cell death. NK cells can be 
“serial killers” and induce cell death of many target cells during their life span [50]. Granzyme-
mediated killings happen when NK cells encounter their first target cells, last in a short time-frame, 
and are critical for serial killing. Death-receptors- or caspase-mediated killings, on the other hand, 
take much longer than granzyme-mediated killings, and can happen only once and usually mark the 
end of NK cell “serial killing” [51]. NK cell population is apparently heterogenous with hypo-responsive 
subsets, intermediately functional subsets and highly potent subsets in regards to the number of kills [50]. 
Studies on NK cell developmental regulation, the detailed signaling proximally at the IS and downstream 
effector functions are providing insights into this heterogeneity.  
 DNAM-1 
DNAM-1 (CD226) is a co-stimulatory receptor and an adhesion molecule in both mouse and human 
NK cells. DNAM-1 in mouse is expressed early on preNKP before the expression of CD122, NKp46, 
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and NKG2A [52]. The receptor recognizes CD155 or poliovirus receptor (PVR) and nectin-2 
(CD122), which are upregulated upon transformation and viral infection [53, 54]. It is important for 
NK cell-dependent tumor control, IS formation, NK memory cell differentiation and contributes to 
pathologies of certain autoimmune diseases [55-59]. DNAM-1 signaling coordinates with Ly49H to 
control expansion and differentiation of memory NK cells in response to MCMV infection. DNAM-
1 and its associated adhesion molecule, leukocyte function antigen-1 (LFA-1) were suggested to be 
markers of both human and murine NK cell education [52, 60]. DNAM-1 expression also endows 
NK cells with higher capacity to proliferate in response to IL-15 [61]. The permissiveness to IL-15 
stimulation conferred by DNAM-1 expression suggested that these two signals might converge to 
control certain critical signaling molecules in NK cells. Therefore, in paper II, we studied the 
cooperation of DNAM-1 and IL-15 signaling in controlling LAT expression. Furthermore, we also 
examined the impact of the potential coordination in NK cell functions.  
 LAT 
LAT (or LAT-1) together with non-T-cell activation linker (NTAL, also named LAT-2) belong to a 
group of transmembrane adaptor proteins (TRAPs). TRAPs act as membrane-associated scaffolding 
proteins that help to recruit signaling molecules to the region that is proximal to the plasma membrane, 
and hence allowing them to be phosphorylated by tyrosine kinases [62]. TRAPs themselves do not 
possess enzymatic activity but can integrate signals by bringing signaling molcules into the close 
proximity to each other. LAT is expressed in T cells, NK cells, mast cells, and platelets, while LAT-
2 is critical for signal transduction in NK cells, B cells and mast cells [63, 64]. Structurally, LAT is 
mostly transmembrane and intracellular with only four extracellular amino acids. LAT is extremely 
acidic and contains nine conserved tyrosine residues [65].  
In NK cells, LAT is particularly critical for signaling downstream of ITAM-associated receptors such 
as NKG2D, Ly49H and NKp46 in NK cells. LAT is activated upon its being phosphorylated by 
ZAP70/SYK, LCK or ITK [65]. Little is known, however, about the inactivation of LAT, which is 
probably mediated via dephosphorylation by CD148 [66]. Tyrosine residues on LAT, upon being 
phosphorylated recruit a range of signaling molecules that activate various pathways, including 
Growth-factor-Receptor-Bound protein 2 (GRB2) family, SLP-76, PLC-γ, and the p85 domain of 
PI3K. LAT molecules oligomerize together with LAT-binding proteins to form clusters that are 
proximal to the plasma membrane, and therefore serve crucial roles to transduce activation signals 
[67, 68]. NK cells from mice that are deficient for both LAT and LAT-2 exhibit defective 
responsiveness downstream of NK1.1. On the other hand, the absence of LAT solely compromises 
functions of IL-2 activated NK cells but does not affect resting cells [64, 69]. LAT expression was 
shown to be down-regulated in lymphokine-activated killer cells as compared to primary murine NK 
cells [64]. This infers a modulation of LAT expression by IL-2. Whether IL-15 controls LAT 
expression has not been studied. In paper II, we explored the regulation of LAT expression by 
DNAM-1/CD155 interaction and IL-15 stimulation.   
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 NK CELL DEVELOPMENT 
 Overview of NK cell development  
The original discovery of NK cells demonstrated the presence of NK cells in human peripheral blood 
[70, 71] and in rodent spleen [5, 72]. Recent discoveries have provided evidences that NK cells are 
present in numerous organs, including BM, spleen, lymph nodes (LNs), skin, gut, liver, tonsils, lung, 
and uterus [73]. Conventional NK (cNK) cells develop in the BM, subsequently migrate to secondary 
lymphoid tissues including LNs and spleen, and peripheral tissues. This thesis focuses on cNK cells 
and hereinafter, NK cells refers to cNK cells. 
In the BM, NK cells develop from CLP, which also give rise to T cells, B cell, and ILC [10, 74]. CLP 
generation, expansion, or maintenance are dependent on FLT3L and IL-7 [75, 76]. The transition 
from CLP to NK cell progenitors (NKP) is marked by the downregulation of FLT3 expression, giving 
rise to preNKP, which do not express any NK cell markers, yet develop exclusively to NK cells as 
shown by in vitro and in vivo development experiments in the original study [74]. A recent study 
demonstrated the expression of DNAM-1 on the preNKP population, demonstrating that this 
population might already exhibit NK signatures [52]. Thereafter, the acquisition of CD122 (IL-
2Rβ/IL-15Rβ) marks the formation of refined NKPs (rNKP) with responsiveness to IL-15 signals 
from surrounding cells [74, 77]. Subsequently, rNKP become immature NK cells (iNK) and then 
mature NK cells (mNK) upon the expression of various receptors and adhesion molecules as well as 
being stimulated by cytokines.  
 Transcription factors in NK cell development  
NK cell lineage specification from BM progenitors depends on soluble and contact-dependent factors 
in the BM niche. The impact of exogenous factors on NK cell differentiation is generally mediated 
via activation of transcription factors, inducing expression of proteins crucial to NK cell homeostasis, 
migration, and functional maturation (Figure 2). Many of these proteins are downstream of IL-15 
signaling and/or affect the expression of the IL-15R and IL-15-signaling molecules. 
Figure 2. Transcription factors crucial for different stages of NK cell development and 
maturation 
Murine NK cell development was so far known to be controlled by three transcription factors: T-Cell-
specific transcription Factor 7 (TCF7), ETS proto-oncogene 1 (ETS1), and E4 Binding Protein 4 
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(E4BP4 or Nuclear Factor, Interleukin 3 Regulated-NFIL3) [78-80]. NFIL3 was shown to act 
downstream of IL-15R signaling through the PDK1-mTOR-NFIL3-CD122 circuit, and is hence 
critical for the expansion and survival of progenitors and committed NK cells [81]. ETS1 KO mice 
showed decreased preNKP and rNKP populations as compared to WT mice, which was suggested to 
be linked to the downregulation of inhibitor of DNA binding 2 (ID2) and T-BET [82, 83]. ETS1 KO 
DX5+ NK cells showed decreased CD122 expression and Chromatin Immunoprecipitation (ChIP) 
qPCR experiment demonstrated binding of ETS1 to CD122 promoter in mNK cells, suggesting 
ETS1-modulated IL-15 signaling [83]. TCF7 was shown to control T-cell specification genes 
including Gata3, Bcl11b, IL2ra, and CD3e [84], yet more explanation for the perturbed NK cell 
development in TCF7 KO mice was not given. In general, transcription factors that are crucial for 
NK cell development act in networks that appear to converge to modulate IL-15 signaling.  
 NK cell maturation 
Following CD122 expression, NK cells acquire expression of surface receptors, adhesion molecules, 
and chemokine receptors, including NKG2D, NCR1 (NKp46), NKG2A, L-selectin (CD62L) and 
Leukosialin (CD43) [77, 85]. The acquisition of CD51 (Integrin αV), CD49b (DX5, Integrin VLA-
2α), CD43, CD11b (Mac-1), killer cell lectin-like receptor subfamily G member 1 (KLRG1) define 
mature populations. The acquisition of inhibitory receptors that recognize MHC-I expressed by 
surrounding cells happens in parallel with the acquisition of adhesion molecules and the migration to 
the periphery. These receptors mark functionally competent subsets, being the “educated” or 
“licensed” subsets [77].  
The most commonly used markers to define the maturation process of murine NK cells are CD27 and 
CD11b. The four subsets segregated by these two markers exhibit differences in functional 
responsiveness, localization, and proliferation [86, 87]. The most immature subset is negative for both 
markers, while the acquisition of CD27 and subsequently CD11b marks a more mature stage. The 
CD27highCD11bhigh and CD27lowCD11bhigh subsets are comparably functionally competent, while the 
CD27highCD11blow population possesses lower reactivity. CD27lowCD11bhigh subset appears to be the 
terminally mature cells as their proliferative capacity is declined as compared to the 
CD27highCD11bhigh counterparts [87]. As the NK cells get mature, they migrate to the periphery, 
meaning that CD27lowCD11bhigh cells are found more in the periphery while CD27lowCD11blow and 
CD27highCD11blow subsets are present more in the BM [87].   
 Innate lymphoid cell development 
Like NK cells, ILC develop from CLP in the BM. ILC progenitors (ILCP) and NKP are overlapping 
populations with shared expression of some surface receptors and transcription factors. ILCP are 
characterized as FLT3-α4β7+ID2+IL-7Rα+ [88]. PreNKP (defined as Lin-CD27+2B4+c-Kit+IL7-
Rα+FLT3-CD122-) and a significant fraction of this population (40 – 50 %) expresses ZBTB16 and 
α4β7 [89]. Similarly, a variable CD122 expression, which is the marker for preNKP to rNKP 
transition, was shown in the ILCP population [89]. The fate decision of these ILCP/NKP population 
is then dependent on niche components. ILC1 and NK cells are dependent on IL-15 [90, 91] while 
IL-7 is crucial for ILC2 and ILC3 differentiation [92, 93]. After being induced by specific cytokines 
and cell-cell interaction, a set of specific transcription factors is expressed and cooperates to drive 
lineage specification.  
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ILCP and NKP formation are both dependent on ETS1, TCF7 and NFIL3. NFIL3 deficiency led to a 
severe reduction in all ILC subsets and NK cells [78, 88]. ILC differentiation from ILCP is dependent 
on GATA3 and while NKP are able to develop, despite subsequently into less mature cells in GATA3 
KO mice [94, 95]. ILCP are also dependent on three other transcription factors namely ID2, Zinc 
Finger And BTB Domain Containing 16 (ZBTB16) and Thymocyte Selection Associated High 
Mobility Group Box (TOX). The involvement of ID2, ZBTB16, and TOX in NKP formation is still 
debated [89, 95-99].  
 NK CELL EDUCATION  
NK cells acquire functional competency and self-tolerance through a process called “licensing” or 
“education”, mostly being MHC-I mediated [100-102]. NK cells that are derived from an MHC-I 
deficient environment or do not express any inhibitory receptors are hyporesponsive [103, 104], 
ensuring self-tolerance in these particular situations. Educated NK cells are more responsive towards 
“missing-self” targets. NK cells belonging to all stages of maturation are capable of performing 
missing-self reactivity, hence the education and the maturation process likely progress in parallel [87]. 
The molecular mechanism of NK cell education is so far not well defined. Several models have been 
proposed to explain NK cell education, including “arming”, “disarming”, “rheostat”, and “retuning” 
models [105]. 
In the arming model, NK cells are initially hyporesponsive until signals through MHC-I-specific 
inhibitory receptors actively endow them with functional competency [106]. Consistent with this 
model, deletion of critical signaling molecules downstream of inhibitory receptors, namely SHP-1, 
SH-2 containing Inositol 5' Polyphosphatase 1 (SHIP1), or Signaling Lymphocytic Activating 
Molecule (SLAM) Associated Protein (SAP), inhibited NK cell education in MHC-I sufficient 
environments and resulted in NK cells whose phenotypes and functions were similar to those arising 
from MHC-deficient environments [107-110]. On the other hand, in the disarming model, NK cells 
are ‘disarmed’ in MHC class I-deficient situations due to overactive activating signals, which in 
MHC-I-sufficient environments would have been counteracted [24]. Activating NK cell receptors 
and ligands on healthy cells that disarm NK cells in this model have not been identified [24]. In the 
“rheostat” model, our lab and others have demonstrated that education is not an on/off system but 
rather quantitative and tunable according to the level of MHC-I expression by surrounding cells [111-
113]. The NK cell responsiveness is dependent on an interplay between the extent of MHC-I 
expression and the density and numbers of inhibitory receptors recognizing endogenous MHC-I [100, 
111, 112]. NK cell education is a reversible, tunable process and requires continuous interactions 
between self-MHC-I and self-specific inhibitory receptors [111, 114]. Experiments employing 
blocking antibodies to interfere with inhibitory signals or cell transfer into an environment with 
different level of MHC-I expression confirmed that NK cell education indeed is tunable. The loss or 
reduction of MHC-I expression down-tuned NK cell responsiveness while the presence of novel 
MHC-I signals up-tuned the reactivity [115-118]. 
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 INTERLEUKIN 15 (IL-15) THROUGHOUT NK CELL BIOLOGY 
 Overview of IL-15 
A wide range of cytokines have been reported to modulate NK-cell homeostasis and functions, 
including IL-2, IL-4, IL-12, IL-18, IL-27, IL-21, IL-9, IL-35, IFN-α, TGF-β and IL-15 [91, 119, 120]. 
Among cytokines that share the common gamma chain (γc) (IL-15, IL-2, IL-21, IL-7, IL-9, and IL-
4), IL-15 demonstrates an absolute importance for orchestrating the entire life of an NK cell, including 
development, proliferation, survival, and activation (Figure 1) [91]. A wide range of cell types, 
including mononuclear cells, activated macrophages, and epithelial cells express IL-15; while IL-
15Rα is expressed on stromal cells, DCs, macrophages, and hematopoietic precursors [121, 122]. IL-
15 and IL-15Rα expression is induced upon infection. IL-15 forms a complex with the IL-15Rα chain 
in the endoplasmic reticulum and the complex is then shuttled to the cell membrane to be presented 
to neighboring cells expressing IL-15Rβ and the common γc (CD132), in a process called “trans-
presentation” [123, 124]. Since IL-15 is a potent pro-inflammatory cytokine, its expression is tightly 
regulated at different levels, including transcription, translation and intracellular trafficking [125].  
 
When the IL-15Rβγ complex on NK cells is activated upon being bound with IL-15/IL-15Rα on 
presenting cells, three different pathways can be initiated, including Janus Kinase- Signal Transducer 
and Activator of Transcription (JAK-STAT), or PI3K-AKT-mTOR (the Mammalian Target Of 
Rapamycin), or MAPK (Figure 3) [126]. The β chain of the IL15-Rβ/γc heterodimer induces 
JAK1/STAT3 activation while the γc component stimulates JAK3/STAT5 activation. Phosphorylated 
STAT3 and STAT5 form either homodimers or heterodimers and translocate into the nucleus to 
trigger transcription of target genes. Binding of IL-15-IL15-Rα to IL15-Rβ/γc also stimulates the 
PI3K-AKT pathway through Src Homology 2 domain-Containing (SHC)- GRB2 signaling, in which 
SHC serves as adaptor protein to activate GRB2 and hence recruits and triggers PI3K activation. In 
the third signaling pathway activated by IL-15, activated GRB2 binds guanine exchange factor Son 
of Sevenless (SOS), which in turn stimulates the RAS-RAF-MAPK pathway.  
 
 
Figure 3. IL-15 signaling. IL-15 is mostly trans-
presented to NK cells via IL-15Rα on 
DCs/monocyte/macrophages. IL-15/IL-15Rα 
interaction with IL-15Rβ/γc triggers three different 
signaling pathways, including JAK/STAT, 
AKT/mTOR and MAPK. The result is the increased 
transcription of genes involved in cell survival, 
proliferation, maturation and immune functions. IL-15 
signaling also induces translation of perforin and 
granzyme B. 
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 IL-15 in NK cell development 
IL-15 is an indispensable cytokine for NK cell development. In mice deficient in expression of IL-
15, IL-15Rα or IL-15Rβ, peripheral NK cells, together with γ𝛿 T cells, NKT cells and memory CD8 
T cells, were almost absent [90, 127, 128]. Analysis of different knockout mice for cytokines sharing 
the γc as part of their receptors revealed that only IL-15-deficient mice showed the defective 
development of NK cells. On the other hand, mice deficient of IL-2, IL-7, IL-21, IL-9 and IL-4 
possess relatively normal numbers of NK cells in the periphery [91, 127, 128]. The deficiency in 
either JAK3 or both STAT5a and STAT5b or mTOR in mice led to the block in NK cell development 
similarly to IL-15 or IL-15R KO mice [129-131]. Along the same line, mice overexpressing IL-15 
have a higher proportion of NK cells, together with memory CD8+ T cells, in the peripheral blood 
[132]. The difference between IL-15 and other cytokines sharing γc in their receptors suggests the 
uniqueness in the signaling pathways of IL-15.  
IL-15 regulates NK cell development by supporting the survival and proliferation of progenitors as 
well as immature NK cells. Binding of IL-15Rα to IL-15Rβ/γc leads to increased survival of NK cells 
by stimulating expression of anti-apoptotic protein B-Cell Lymphoma 2 (BCL-2) and Myeloid Cell 
Leukemia 1 (MCL-1) downstream of JAK/STAT pathways and suppressing expression or activities 
of pro-apoptotic proteins FOXO, BIM and p53 Upregulated Modulator of Apoptosis (PUMA) 
through the PI3K-mTOR-AKT pathway. The proliferation effect is due to activation of the 
JAK/STAT and MAPK pathways, which increase expression of the proto-oncogenes c-myc, c-jun, 
and c-fos [133, 134].  
 IL-15 in NK cell maturation and functions 
The link between IL-15 and NK-cell maturation has been noted in several studies. IL-15 stimulation 
can trigger NK cell maturation through the mTOR-AKT-FOXOs-T-BET signaling pathway. IL-15-
induced PI3K phosphorylates mTOR, which in turn phosphorylates AKT on Ser 473, leading to 
phosphorylation of the FOXO transcription factors and inducing their nuclear export [129, 135]. 
FOXOs, in particular FOXO1, have recently been reported to negatively regulate NK cell maturation 
through inhibiting transcription of T-BET, an important transcription factor driving NK cell 
maturation [136]. Furthermore, NK cells from IL-15 or mTOR KO mice were shown to be less mature 
[91, 129]. Likewise, human NK cells displayed a more mature phenotype, CD56lowCD16+, in 
response to the treatment with rhIL-15 plus IL-15Rα-Fc [137].  
Relating to its role in supporting NK cell maturation, IL-15 also stimulates effector functions of NK 
cells. In vitro and in vivo experiments demonstrated that IL-15 trans-presentation by DCs primed NK 
cell functions upon the infection-like conditions induced by lipopolysaccharide (LPS) or TLR 
agonists [138, 139]. IL-15 modulates NK cell activation by increasing the translation of perforin and 
granzyme B, the important cytolytic molecules that mediate target cell killing by NK cells, without 
affecting the abundance of their mRNA [140]. It remains unknown whether, under steady-state 
conditions, IL-15 also supports NK cell functions or contributes to the education process. It is known 
that the education process is associated with shaping of the inhibitory receptor repertoire [141]. Using 
a transgenic mouse model with DCs as the only cell type expressing IL-15, it was reported that IL-15 
from DCs was important for the up-regulation of several inhibitory and activating receptors on NK 
cells, including Ly49A/D, Ly49G2, Ly49I and Ly49D [142]. Indeed, many known downstream 
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molecules of the IL-15 receptor are essential for NK cell effector functions, including c-jun, c-fos, 
IFN-γ, and TNF-α [126]. Therefore, whether IL-15-IL-15Rα presentation, especially from DCs, 
contributes to NK-cell acquisition of the functional potency at the steady-state is a worth-to-pursue 
question and is the main research aim for paper I.  
 DENDRITIC CELLS AND NK CELLS 
 Overview of dendritic cells 
DCs make up a critical subset of the innate immune system. They present foreign antigens to induce 
adaptive immune responses and self-antigens to induce tolerance. DCs are classified into 
conventional, plasmacytoid, and monocyte-derived DC based on their developmental paths, 
locations, receptor expression, and functions. Conventional DCs (cDCs) express high levels of 
CD11c and MHC-II. Zinc Finger And BTB Domain Containing 46 (ZBTB46), FLT3, c-KIT and 
GM-CSF regulate the development of cDCs [143]. cDCs populate both lymphoid and non-lymphoid 
tissues, and are superior compared to other DC subsets in sensing and capturing pathogens as well as 
self-antigens and present to T lymphocytes in the draining LNs [144]. Beside the roles in presentation 
and activation of T cells, cDCs also produce and wide range of cytokines and chemokines to modulate 
other immune cells including NK cells, e.g. IL-12, IL-18, IL-15, IL-1 and TNF-α [145]. As opposed 
to LNs, spleens contain only lymphoid tissue-resident cDCs [146]. Plasmacytoid DCs (pDCs) mainly 
reside in the primary and secondary lymphoid tissues and express TLR7 and TLR9 to sense viral 
infection. The development of pDCs is impaired in the absence of E2-2 transcription factor [147]. 
Monocyte-derived DCs, as their name indicates, are originally CD14+ cells, which extravasate, 
upregulate MHCII, CD11c and costimulatory receptors to become DCs. Acting similarly to cDCs, 
monocyte-derived DCs become mature and migrate to draining LNs to present antigens to T 
lymphocytes [148]. In study I, we focused on the roles of cDCs (denoted hereinafter and in the paper 
as DCs) on NK cell homeostasis and functions in the mouse spleens.  
 Dendritic cells in NK cell homeostasis and functions 
As opposed to T lymphocytes, NK cells were first identified to readily display effector functions 
without any prior priming from other immune cells. However, during the last decade, extensive 
studies have shown that myeloid cells, including neutrophils, macrophages and DCs, are required for 
NK cell activation [138, 149]. In vitro studies demonstrated that the cytotoxicity and IFN-γ production 
of NK cells were increased in the presence of DCs [139]. In this study, DCs were getting mature with 
TNF-α, LPS, or mycobacterium tuberculosis [139]. In addition, administration of FLT3L led to the 
expansion of DCs and hence also increased the mature NK cell pool by enhancing their survival and 
proliferation [150].  
Recently, several mouse models in which DCs can be specifically depleted (CD11c.DTR, 
CD11c.DOG, and CD11c.DTRluci) have been created to facilitate the investigation of DC-NK 
interaction in vivo [138, 151-153]. Common to these models is the expression of human diphtheria 
toxin receptor (DTR) under the control of CD11c promotor; hence CD11chighMHCIIhigh cells can be 
depleted upon diphtheria toxin (DT) injection. Using these models, it was established that, under 
inflammatory conditions, DCs are crucial for the activation and homeostasis of NK cells [151].  
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Both soluble factors and contact-dependent molecules have been implicated in DC mediated 
modulation of NK cell activation in vitro and in vivo. From in vitro co-culture experiments and 
MCMV infection models, it has been shown that type I interferons and NKG2D interaction with its 
ligands are required for NK cell cytotoxicity, IL-12 and IL-18 for IFN-g production, 
CXC3CL1/CXC3CR1 for IFN-g production, and IL-15 for proliferation and survival of NK cells 
[149, 154-158]. In addition, in vivo DC-depletion experiments demonstrated that NK cell activation 
upon TLR ligand stimulation was enhanced by IL-15 trans-presentation from DCs [138].  
Despite the well-characterized priming process happening upon the pathogen challenge, little is 
known about whether DC-NK interactions at steady-state play a role in functional acquisition or 
functional maintenance of NK cells. Therefore, in paper I, we studied the kinetic changes of NK 
cells upon DC depletion in mice, with regard to survival, proliferation, maturation, and functional 
responsiveness.  
 IL-15 priming 
IL-15 priming refers to a process in which NK cells acquire a heightened activation state in the LNs 
owing to their contacts with cytokines or DCs, and thereafter are able to perform enhanced effector 
functions in peripheral tissues. Lucas and coworkers demonstrated that NK cells require DCs for their 
optimal effector functions upon infections [138]. Upon TLR stimulation, DCs rapidly upregulated 
IL-15 and IL-15Rα in a process that is dependent on type I IFNs. During a local infection, NK cells 
upregulate CD62 ligand and are then recruited to the draining LNs, where the priming takes place 
[138]. In LNs, recruited NK cells are present in the outer paracortex just beneath B cell follicles, 
where they make long and stable interactions with activated DCs [159]. In the absence of infection, 
more than 50 % of NK cells also form contacts with DCs in the LNs [160]. Even though 90 % of the 
contacts last less than 900 seconds, NK cell interaction with IL-15 at the steady-state might be 
functionally relevant. In paper III, we aimed at studying the functional outcomes of short time IL-
15 stimulation, whether it is long lasting and its molecular mechanisms.  
 METABOLISM IN NK CELL FUNCTIONS 
 Metabolism in immune cell functions 
Metabolic signaling has been shown to be important for differentiation and activation of various 
immune cell types [161]. Naïve T cells primarily rely on oxidative phosphorylation (OXPHOS) as 
their energy source. On the other hand, activated T cells switch to glycolysis for an increased 
anabolism for cell proliferation and a faster energy-supply, a process that is similar to the switch in 
cancer cell metabolism called the Warburg effect [162-164]. When activated T lymphocytes become 
the memory cells, they remain quiescent by changing back to more energy-producing metabolic 
pathways, including OXPHOS and fatty acid oxidation [165]. Therefore, in immune cells, metabolic 
changes are crucial to provide cellular energy in a right time frame and intermediates that are 
important for immune functions.   
One of the responses of immune cells upon pathogen infection is the production of oxidative 
molecules including reactive oxygen species (ROS) and nitrogen reactive intermediates. ROS include 
free radicals, such as superoxide (O2-) and hydroxyl radical (•OH), and non-free radical oxidative 
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molecules, such as hydrogen peroxide (H2O2) and singlet oxygen (1O2). The formation of superoxide 
is mediated by membrane-associated enzymes or cytoplasmic enzymes such as NAD(P)H oxidases 
and xanthine oxidases and redox-reactive compounds of electron transport chain in mitochondria, 
such as semi-ubiquinone. ROS are not only byproducts of cellular metabolism but also regulate 
multiple cellular signaling cascades via the activation of kinases, the inhibition of  tyrosine 
phosphatases, and the induction of cytosolic Ca2+ by acting on calcium channels on plasma membrane 
or endoplasmic reticulum [166]. Treatment of the T cell membrane with H2O2 increased 
phosphorylation of proximal signaling molecules such as LCK, FYN, SYK, ZAP70, and CD3V [167]. 
In addition, H2O2 also enhanced the capacity of T cells to produce IL-2 and IL-4 and to proliferate in 
response to CD3/CD28 stimulation by activating directly NF-ĸB [168].  
 IL-15, metabolism, and NK cell functions 
IL-15 stimulation is known to induce metabolic changes in NK cells, in particular through mTOR 
activation [169]. IL-15 stimulation, for at least 16 hours, in mouse and human NK cells induces both 
glycolysis and OXPHOS [129, 169]. In addition, glucose-driven OXPHOS was shown to be critical 
for IFN-γ production triggered via activating receptor stimulation, which was bypassed by a treatment 
with a high-dose IL-15 [170]. Inhibiting mTORC1, a key metabolic regulator induced by IL-15, 
compromised NK cell cytokine production and cytotoxicity in vitro and in vivo [169, 171]. As 
opposed to T cells, studies on the effects of ROS on NK cell functions are scattered. Blazquez and 
co-workers showed in 1997 that antioxidant treatment reduced NF-ĸB activation and NK cell 
cytotoxicity [172]. In obesity, higher level of lipid accumulating in NK cells impairs glycolysis and 
OXPHOS, and hence their anti-tumor functions [173]. Whether metabolism and ROS are involved in 
short-time IL-15 stimulation has so far not been studied and hence has become one of the questions 
that we addressed in paper III. 
 FOXO TRANSCRIPTION FACTORS  
 Overview of the forkhead box transcription factors of the O class (FOXO) 
transcription factors  
FOXO is a family of transcription factors that integrates external information, including growth 
factors and stress signals, to modulate various cellular processes. At the organism level, FOXO 
affects life span, metabolism, and fertility [174, 175]. At the cellular level, FOXO proteins modulate 
metabolism, stress response, cell fate decisions, and protein homeostasis [176]. FOXO controls cell 
homeostasis by regulating genes involved in cell cycle arrest and apoptosis, including cyclin 
dependent kinases (CDK), B cell lymphoma 6 (BCL6), FASL, TNF, etc. In a condition of starvation, 
FOXO controls gluconeogenesis, propensity for food intake and redox balance, by influencing 
expression of apolipoprotein C3 (APOC3), G Protein-Coupled Receptor 17 (GPR17), Superoxide 
dismutase 2 (SOD2), etc [177]. FOXO also regulates protein homeostasis by controlling expression 
of genes involved in mitophagy, proteasomal breakdown, and autophagy [178-180]. In addition, 
FOXO controls pluripotency via SOX2 and OCT4 [181]. Furthermore, emerging data show that 
FOXO proteins serve as critical transcription factors for various aspects of the immune system [182].  
Due to the critical roles of FOXO in stress response and cell homeostasis, these proteins have been 
considered as tumor suppressors [183]. The activity of FOXO is controlled by the integration of 
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multiple signals. For example, independent phosphorylation of FOXO at three different sites by 
PI3K/mTORC2/AKT leads to their nuclear export and degradation [184, 185]. In addition, FOXO 
activity is also controlled acetylation, methylation, and ubiquitinylation [182]. 
 FOXO in immune differentiation and immune responses 
FOXOs are crucial for a wide range of immune processes. FOXO1 is critical for the survival and the 
homing of naïve T cells by controlling the expression of L-selectin, C-C chemokine receptor type 7 
(CCR7) and IL-7Rα [186]. In addition, FOXO1 is involved in various stages of B cell differentiation, 
by regulating the expression of IL-7Rα, recombination activating gene 1,2 (Rag1,2), L-selectin, and 
activation-induced cytidine deaminase (AICD) [187-189]. FOXO1 and FOXO3a together are 
important for forkhead box P3 (Foxp3) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) 
expression and transforming growth factor β (TGF-β)-mediated downregulation of T-BET, which is 
crucial for regulatory T cell differentiation [190, 191]. Furthermore, FOXO3 controls interferon 
response factor 7 (IRF7) expression, which is critical for antiviral response of macrophages, or IL-6, 
monocyte chemoattractant protein 1 (MCP-1), and IFN-γ expression, which is important in DCs-
mediated induction of T cell response [192, 193]. 
FOXO proteins regulate the survival of immune cells by being downstream of activating receptors 
and inflammatory cytokine receptors. Stimulations via NK-cell activating receptors, TCR or γc 
receptors induce PI3K-AKT pathway, which phosphorylates and retains FOXO in the cytoplasm 
(Figure 4). In the absence of these signals, nucleus FOXO induces the upregulation of proapoptotic 
genes (Bim, CD95/CD95L, Puma), and cell cycle inhibitor genes (p27Kip1) [194-197].  
 
 
 
 
Figure 4. FOXO signaling in immune cells. 
Stimulations via NK-cell activating receptors, 
TCR or γc receptors induce the activation of 
AKT/mTOR or MAPK pathways which 
phosphorylate FOXO proteins. Phosphorylated 
FOXO proteins are exported from the nucleus, 
ubiquitinylated, and degraded. On the other 
hand, oxidative stress activates JNK which 
phosphorylates FOXO at a different site, and 
retain FOXOs in the nucleus to induce 
transcription of target genes. Target genes of 
FOXOs are involved in cell cycle arrest, DNA 
repair, ROS detoxification, metabolism, 
apoptosis, and immune functions.  
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 FOXO in NK cells   
Previous studies have reported conflicting findings on the roles of FOXO1 in NK cell development 
[136, 198]. Deng et al. demonstrated that FOXO1 deficiency specifically in NK cells (Ncr1+iCre 
FOXO1flox/flox) increased NK cell maturation and homing to LNs via the upregulation of T-BET and 
the downregulation of L-selectin. In this study, NK cell development was unperturbed with normal 
NK cell numbers in both BM and spleen [136]. Furthermore, FOXO1-deficient NK cells displayed 
an enhanced capacity to produce IFN-γ in response to IL-12 plus IL-18 stimulation, to kill YAC-1 
cells in vitro, and to control B16F10 melanoma cells in vivo [136]. On the other hand, Wang et al. 
used a similar mouse model, yet with a different Ncr1+iCre line, and showed that NK cell number in 
both BM and spleens were significantly reduced in the absence of FOXO1 due to an increase in 
ROS-mediated apoptosis. Wang and co-workers demonstrated that phosphorylated FOXO1 binds to 
Autophagy related protein 7 (ATG7) in the cytoplasm of immature NK cells, thereby inducing 
autophagy which protects NK cells from apoptosis-induced cell death [198]. As opposed to Deng et 
al., Wang et al. reported a decreased function of FOXO1-deficient cells as they killed YAC-1 cells 
and controlled MCMV less efficiently as compared to littermate controls [198]. The contradicting 
data in the two studies were accounted to mouse housing conditions and the Ncr1+Cre lines used 
[198].  
In paper IV, we also have made Ncr1+iCre FOXO1flox/flox to resolve the discrepancies between these 
two published works. Furthermore, we also made Vav1+iCre FOXO1,3flox/flox to study the potential 
roles of FOXO1,3 in NK cell development as Vav1 is readily expressed in hematopoietic progenitors 
[199]. In this study, we also investigated the changes in NK cell maturation and receptor expression 
upon FOXO1,3 depletion and possible molecular mechanisms underlying any NK cell 
developmental effect.  
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2 RESULTS AND DISCUSSION 
 DENDRITIC CELLS THROUGHOUT MURINE NK CELL BIOLOGY 
 Dendritic cells are important for the homeostasis and functions of NK 
cells at steady-state  
Making used of a conditional cell-depletion mouse model in which diphtheria toxin receptor (DTR) 
is expressed under the control of the CD11c promotor (CD11c.DOG), we explored the kinetic 
changes of NK cell homeostasis and functions in BM and spleens (paper I). We have followed the 
changes in NK cell number and functions after up to 10 days of DC depletion. Even though DTR 
is expressed under the CD11c promotor control, we could confirm previous data that NK cells, with 
intermediate CD11c expression, were not affected directly by the DT treatment [151]. This key 
prerequisite for the study was confirmed by the fact that, in the spleen, DCs were readily depleted 
after 24 hours of DT injection while NK cell numbers remained unchanged. Using this model, we 
showed that depletion of DCs at the steady-state compromised NK cell homeostasis, perturbed the 
differentiation process with the accumulation of immature cells, and reduced the functional 
responsiveness of NK cells. The effects of DCs on NK cells were dependent on IL-15 expressed 
by DCs, as transferring back IL-15 KO DCs to DC-depleted mice did not restore missing-self 
killing capacity while the transfer of WT DCs did. We also showed the downregulation of genes 
involved in IL-15 pathway as well as the lower IL-15 responsiveness of NK cells obtained from 
DC-depleted mice (Figure 5).  
 
Figure 5. DC-depletion under 
steady-state condition affects NK 
cell homeostasis and functions. 
Early upon DC depletion (2-4 days- 
green boxes), NK cell numbers in both 
BM and spleen were reduced. IL-15 
signaling was compromised in NK 
cells in the absence of DCs, as 
measured by the phosphorylation of 
STAT5, mTOR, AKT and p38. 
Expression of IL-15 target genes was 
down-regulated, including jun, fos, 
ifng, tnf, lat, il21r, kit. As a result, NK 
cell capacity to produce IFN-γ and kill 
“missing-self” targets was decreased. 
Late after DC depletion (6-10 days- 
brown boxes), NK cell homeostatic 
proliferation was induced, leading to 
the accumulation of immature subsets 
and inhibitory receptor negative 
subsets.  
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Using CD11b and CD27 as markers for NK cell maturation in mice, we found that there was an 
accumulation of the most immature subset, CD27lowCD11blow and a decrease in the mature subset, 
CD27highCD11bhigh. The accumulation of the immature subset starting to be apparent at day 4 might 
be accounted by their high proliferation rate as compared to other subsets. Therefore, the changes 
in the maturation status of splenic NK cells appeared to happen in parallel with the increased 
proliferation rate upon DC depletion. The work in this paper was performed from 2012 till 2016 
when it was published and the knowledge on ILC was still limited. Therefore, little was explored 
and discussed in the paper regarding to the nature of the CD27lowCD11blow subset. In BM, this 
subset was shown to be largely ILC1 [89]. Therefore, it is possible that there was an expansion of 
ILC1 in the spleen upon DC depletion which was associated with a general reduction in Ly49 
expression in the total NK1.1+CD3- population. However, ILC1 linage specification and 
maintenance is also dependent on IL-15 [200]; and hence, the ILC1 population might be 
compromised similarly to NK cells. Future experiments to investigate the nature of the expanded 
CD27lowCD11blow population as well as the impact of DC depletion on ILC1 will shed light on the 
dynamic regulation of innate cell homeostasis by accessory cells.   
In this study, we provided an evidence that, under non-inflammatory conditions, dendritic cells 
support NK homeostasis and functions via the effect of IL-15 signals. Upon 4 days of DC 
depletion, we detected that basal mTOR and AKT phosphorylation was reduced. Furthermore, 
gene set enrichment analysis of gene array data revealed that NK cells from DC-depleted mice 
down-regulated genes downstream of STAT5 pathway. In vivo functional assays demonstrated 
that IL-15 from DCs are crucial for missing-self reactivity against MHC-I deficient targets. In this 
experiment, transferring back of WT DCs restored NK cell functions from DC-depleted mice to 
the same level of NK cells from non-DC-depleted mice, while adding back IL-15 KO DC did not 
exert a similar effect. Nevertheless, add-back of IL-15 KO DCs still augmented the responsiveness 
of NK cells as compared to the non-add-back situation. Therefore, DCs might provide other factors 
that support NK cell functions at the steady-state, for example IL-12, IL-18, or MHC-I signal 
(discussed below in 2.1.2).  
One observation consistent with the original study was that DC depletion resulted in the 
neutrophilia in the spleen of DC-depleted mice [151]. As a follow-up of paper I, we asked the 
question whether neutrophilia blurred the effect of DC depletion on NK cell development. In order 
to address this point, we injected A18 antibodies in an attempt to deplete neutrophils in the DC-
depleted mice. We were able to restore the neutrophil number in the spleen back to a same number 
with non-DC-depleted mice and to partially reduce the neutrophil number in the BM. Upon 6 days 
of the antibody injection, NK cell population in the BM and spleen was reduced from mice with 
both DT and A18 injection to a higher extent as compared to DT injection alone. This suggests the 
coordinating roles of DC and neutrophils in NK cell development in the BM and homeostasis in 
the spleen. A thorough literature search did not give many evidences on the expression of IL-15 by 
neutrophils at the steady-state. A study detected IL-15 expression intracellularly and on the cell 
surface upon LPS treatment, but barely detected it in the absence of the stimulant [201]. 
Nevertheless, neutrophils possess the expression of all three components of the IL-15R complex, 
including IL-15Rα, IL-15Rβ and γc [202-204]. Therefore, we cannot exclude the possibility that 
neutrophils take up IL-15 from the BM niche and trans-present to NK cells and being the factor 
that blurred the effect of DC depletion in NK cell development in our model. Further experiments 
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to dissect carefully neutrophil as well as monocyte compartments in the BM will address the 
contributions of different hematopoietic cells to NK cell development.  
Our system employs the cellular effect of DT, a potent toxin from Corynebacterium diphetheriae, 
which blocks cellular protein synthesis and induces cell death via apoptosis without inducing 
inflammation [205, 206]. Rodent cells also possess DTR, however, with three amino-acid different 
from human DTR, are much more resistant to DT. Transgenic mice with human DTR being 
expressed under specific promotors, in our study the CD11c+ promotor, are useful for the selective 
depletion of CD11chigh cDCs in a time-controlled manner. LC and pDC, on the other hand, are 
spared in this model [207]. However, as other DTR-DT models, CD11c.DOG mice were shown to 
develop antibody against DT and hence DC population was restored beyond 11 days of DT 
injection and kinetic study was not possible after this time point [151].  
A limitation with our model was that CD11c is not only expressed on DCs but also on macrophages, 
NK cells, NKT cells, and some CD11c+ T and B cells [208, 209]. Identifying unique markers for 
DCs or specific DC subsets has been a great challenge. Similar to CD11c, other DC markers, 
including FLT3, LYSM, CSF1R, CX3CR1, and CD11b, are also expressed by DC-related linages 
including monocytes and macrophages [209, 210]. In addition, the expression of the many markers 
is not stable and subjected to changes with the tissue niche components, including surrounding cell 
types and cytokine availability [209, 211]. At the same time with the starting of the work in paper 
I, a study showed a specific transcription factor, ZBTB46, identifies early committed cDC 
precursors and cDC, but not pDC, monocytes, or macrophages [143]. Even though ZBTB46 is 
dispensable for cDC development in vivo, its expression is crucial for the suppression of G-CSF 
and leukemia inhibitory factor receptors that usually happen during cDC development [143]. 
Making a new mouse model with expression of DTR under the control of ZBTB46 promotor will 
provide an opportunity to study more specifically the role of cDCs on NK cell development, 
homeostasis, and functions. In addition, further experiments to dissect the roles of a specific cDC 
subsets on NK cell development, homeostasis and functions can be done by using transgenic mice 
with expression of CD11c-driven Cre recombinase that targets the depletion of IRF8, BATF3, or 
components of the Notch signaling [143, 212-214]. 
 Can dendritic cells be the main cell type providing IL-15 for NK cell 
development in the BM? 
The formation and/or maintenance of splenic NK cells was shown to be dependent on IL-15 derived 
from hematopoietic cells but not stromal cells [150]. Regardless of this finding, the exact cell type 
residing in same BM niche with NK cells and supporting their development is still unknown. The 
hematopoietic candidates are monocytes, macrophages, DCs, and neutrophils, which express IL-
15Rα. Indeed, IL-15 is required to be trans-presented to support NK cell development, as mice with 
only free IL-15 in the serum, but not IL-15α/IL-15 complex formed on the surface of BM DCs, 
possess significantly lower NK cell population size as compared to WT mice or parent mice with 
IL-15Rα expression [215]. Likewise, human NK cells arising from human hematopoietic stem cells 
in a transplantation mouse model of Rag2/γc KO, which do not have a lymphoid system [216], 
were significantly higher in the presence of exogenous rhIL-15/R but not soluble IL-15 [137].  
Nevertheless, the exact cell type that provides IL-15 signals to support BM NK cell development 
is yet to be discovered.  
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So far, DCs have been shown to have numerous contacts with NK cells and reside in the same areas 
in the T cell zone in the LNs [160]. Yet, no study has been done to explore the localization and 
contacts between DCs and NK cells in the BM. Interestingly, a study using IL-15 reporter mice 
only demonstrated that in BM VCAM+ stromal cells are the main source of IL-15 [122]. Therefore, 
it is still unclear how much IL-15 is produced by BM DCs and whether DCs and NK cells are in 
frequent contacts in the BM like in the LNs.  
 Dendritic cells might provide MHC-I signal for NK cell education  
The cell type that provides MHC-I signal essential for NK cell education is not yet known. Mature 
DCs were shown to form “regulatory synapses” with NK cells, which is a mixture of lytic and 
inhibitory synapse, with the actin reorganization in DCs and the accumulation of MHC-I molecules 
at the synapse [217]. However, little is known about NK-DC synapse under resting conditions. 
Resting NK cells do not kill immature DCs at low NK/DC ratio but induce their activation [12], 
suggesting that regulatory synapses might present between resting NK and immature DCs. We 
asked, in paper I, whether MHC-I expression on DCs was important for NK cell functions. Indeed, 
transferring back MHC-I KO DCs to DC-depleted mice did not restore the missing-self reactivity 
of NK cells as compared to WT DCs (Figure 6). However, we could not exclude that transferred 
MHC-I KO DCs were killed by the host NK cells. We actually showed the presence of transferred 
MHC-I KO DCs in DC-depleted mice by CD45 markers, yet at a lower fraction as compared to 
transferred WT DCs. Therefore, we were still unsure of whether indeed MHC-I expressed by DCs 
is important or the number of transferred MHC-I KO DCs that have reached lymphoid organs was 
not sufficient. Further experiments to confirm this finding as well as studies on MHC-I KO mice 
with MHC-I expressed solely by DCs will answer this point.  
Figure 6. Transfer of WT DCs but not IL-15 KO or MHC-I KO 
DCs restored the in vivo missing-self reactivity of NK cells from 
DC-depleted mice. Design of the experiments was the same as 
Figure 4e from Paper I.  
 
 
 
 
 IL-15 THROUGHOUT MURINE NK CELL BIOLOGY 
 Functional effects of IL-15 short-time priming 
NK cells bump into DCs with a high frequency and for very short durations in the LNs [160]. In 
paper III, we investigated whether the short-time IL-15 stimulation (five minutes) leaves any 
functional impact on NK cells, if it is long lasting, and what the molecular mechanism is. We have 
found that a five-minute stimulation augmented the calcium flux, IFN-γ production, degranulation 
of NK cells in response to activating receptor crosslinking, and their cytotoxicity towards YAC-1 
cells. The priming could be explained by the crosstalk between IL-15 and activating receptors as 
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IL-15 stimulation alone induces phosphorylation of proximal signaling molecules downstream of 
activating receptor, including LCK and SLP-76.  
The augmentation of calcium flux induced by five-minute treatment of IL-15 was long lasting after 
the removal of the cytokine, indicating a physiological relevance of this phenomenon. Based on 
these findings, we formulated a model for IL-15 priming of NK cell functions. In draining LNs, 
upon encountering with IL-15-transpresenting cells, DCs, even for a short period of time, the 
activation of activating receptor signaling molecules was increased above the basal level in 
unprimed cells. The small magnitude of activation, which is not sufficient to induce calcium flux, 
degranulation, or IFN-γ production, might be relevant. This helps to avoid potentially harmful 
production of inflammatory cytokines or cytotoxicity against LN endogenous cells, including DCs, 
endothelial cells, and stromal cells. Bearing a lower threshold for activation, primed NK cells 
migrate to the periphery and are ready to fight infections and control transformed cells. At the 
steady-state, there is a pool of NK cells in the peripheral tissues, being more functionally responsive 
due to previously encountering with DCs in the LNs. In fact, the brief contacts with IL-15 signal 
might help to avoid exhaustion induced by long-term IL-15 stimulations, which was observed for 
continuous IL-15 treatment in both human and mouse NK cells [218, 219]. In addition, 
overexposure to IL-15 signaling in a transgenic mouse model and uncontrolled autocrine/paracrine 
IL-15 expression led to a fetal leukemia of NK cells and T cells [132, 220]. This model points to a 
non-innate characteristic of NK cells, which is the requirement of accessory cells to maintain an 
optimal function state.  
We have shown that IL-15/Rα complex also exerted a priming effect similarly to soluble IL-15. 
The first attention is on the efficacy of IL-15/Rα as compared to soluble IL-15. IL-15 acts mostly 
through trans-presentation due to its high affinity to IL-15Rα [124, 221]. The presence of IL-15Rα 
increased IL-15 efficiency to induce proliferation of CD8+ and NK cell by more than 50 times 
[222]. It was intriguing that the same dose (10 µg/ml) of IL-15/Rα complex and IL-15 exerted 
comparable priming effects on calcium flux triggered via NK1.1 stimulation.  However, our data 
on similar effects of IL-15 and IL-15/Rα complex might not be contradictory to previous finding. 
In fact, our study analyzed Ca2+ flux already after 20 minutes while Rubinstein et al. performed a 
much longer incubation of three to four days and investigated only the proliferation rate [222]. 
Indeed, the stimulation length of a cytokine might decide the cellular effects. This is in agreement 
with our findings that 20-minute IL-15 stimulation did not induce metabolic changes while 22-hour 
incubation did.  
We have provided molecular explanations for short-time IL-15 priming, including crosstalk via 
JAK3 and ROS induction (Figure 7). We made used of the selective JAK3 inhibitor (CP-690550), 
which has been proved in vitro and in vivo to severely block the development, proliferation, and 
activation of NK cell and CD8+ T cell [223]. JAK3 inhibition dampened the upregulation of 
STAT5 phosphorylation induced by five-minute IL-15 stimulation, proving the efficiency of the 
inhibitor on IL-15 signaling. In addition, the inhibition compromised IL-15 mediated induction of 
SLP-76 and LCK phosphorylation. Functionally, IL-15 mediated induction of IFN-γ and 
degranulation triggered via NK1.1 crosslinking was also dampened by the JAK3 inhibitor. Taken 
together, our data suggested that IL-15 might crosstalk with activating receptors proximally via 
JAK3 and LCK/SLP-76. JAK3 crosstalk between IL-15 signaling and activating receptor signaling 
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on NK cells was suggested in another study for the receptor NKG2D [224]. In this study, JAK3 
was shown to associate with CD122 and γc in the NK cell line KY-1 or in LAK cells treated or 
untreated with pervanadate using co-immunoprecipitation (co-IP) experiments [224]. It would be 
the ultimate goal to prove physically that JAK3 interact with proximal signaling molecules 
downstream of NK1.1, i.e. FcRγ [225]. However, initial attempts to pull down FcRγ from primary 
unactivated murine NK cells were not successful due to its low expression level. Future co-IP 
experiments using NK cell lines expressing tagged JAK3 or FcRγ will possibly demonstrate the 
physical interaction between these two molecules upon a short-time IL-15 stimulation.  
 
Figure 7. IL-15-short time priming 
effects on NK cell functions. Short-time 
IL-15 encounter (with soluble IL-15 or IL-
15/Rα complex) induces JAK3 
phosphorylation which cross-talks with 
proximal activating receptor signaling 
molecules including LCK and SLP-76. The 
crosstalk leads to the enhanced IFN-γ 
production, degranulation, and cytotoxicity 
of NK cells. Short-time IL-15 stimulation 
(20 minutes) does induce AKT/mTOR, 
JAK/STAT, MAPK pathways and ROS 
production, but not metabolism.  
 
Further studies with more advanced techniques would shed light on the in vivo relevance of brief 
contacts between NK and DCs in the LNs. A photodegradable IL-15/IL-15R complex might be 
used to time the contacts more precisely, i.e. for 15 seconds, 30 seconds, 1 minute, 2 minutes and 
so on. Afterwards, target cells could be added directly to the NK cell culture and the calcium release 
might be monitored by microscopy to minimize the time that the cells are kept on ice. NK cells 
could also be left alone for certain periods of time between IL-15 being degraded and target cells 
being added, this is to study the long-lasting effect of short-time IL-15 contact. In a more advanced 
set-up, DCs could be transfected with photodegradable IL-15 and be used to replace IL-15/IL-15R 
complex. In this setting, DCs could also be activated with TLR agonist to study the kinetic of 
priming effects in the presence of infection. With the proposed settings, the functional relevance of 
short-time IL-15 priming could be explored in more detail.  
 IL-15 and metabolism in NK cell functions 
Since long-term IL-15 stimulation was shown to induce metabolic changes in NK cells, we asked 
whether short-time IL-15 stimulation also resulted in a similar enhancement. mTOR mediates IL-
15 induced metabolic changes in NK cells as mTOR inhibition compromised the effects [169]. In 
paper III, we found that mTOR and downstream molecules of mTOR, including S6 and 4EBP1, 
displayed an increased activation in response to 20-minute IL-15 stimulation. Yet to our surprise, 
we did not observe any changes in either glycolysis or OXPHOS upon a 20-minute stimulation 
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with IL-15. Therefore, we deduced that short time IL-15 stimulation augmented NK cell function 
independently of metabolic changes despite mTOR activation. MTOR induces metabolic changes 
via selectively modulating the translation of nuclear-encoded mitochondrial proteins as well as the 
upregulation of genes involved in nutrient uptake proteins, metabolic enzymes and mitochondrial 
structure proteins [226-228]. Like other immune cells, NK cells require an optimal level of cellular 
metabolism for functional responsiveness [170]. However, mTOR-mediated augmentation of both 
glycolysis and OXPHOS is dependent on protein translation, which is not likely to happen within 
five minutes. Therefore, it was reasonable to see a delay between mTOR activation and metabolic 
changes. Nevertheless, we do not exclude the involvement of metabolic changes in short time IL-
15 priming. In the later stage when primed NK cells leave the sites of IL-15 contacts and migrate 
to the periphery, the activated mTOR might lead to metabolic changes. Analyzing primed cells 
upon a certain period of IL-15 starvation will address this question.   
Despite the failure to detect any metabolic change upon short-time IL-15 stimulation, we have 
found a small increase in ROS production. ROS treatments themselves increased phosphorylation 
of proximal signaling molecules downstream of activating receptors, including LCK and SLP-76. 
The treatments with a ROS scavenger, N-acetylcysteine (NAC), reduced the augmented 
phosphorylation of LCK and SLP-76, which was induced by IL-15 stimulation. This indicates that 
ROS might contribute to the increased baseline in activation of signaling molecules upon IL-15 
stimulation. However, we have also detected significant decreases in the phosphorylation of LCK 
and SLP-76 in untreated cells. Taken together, ROS might contribute to NK cell functional 
responsiveness by their effects in both resting and IL-15-treated cells.  
 DNAM-1, IL-15 in NK cell development and functions  
In paper II, we showed that DNAM-1 and IL-15 signals coordinate to control LAT expression, 
which was crucial for NK cell functional responsiveness in response to NK1.1 stimulation (Figure 
8). DNAM-1+ NK cells possess a higher level of LAT protein and the absence of DNAM-1 or its 
ligand, CD155, compromised LAT expression. LAT expression was also modulated by IL-15 
stimulation and IL-15-induced upregulation of LAT was observed only for the DNAM-1+ subset. 
The relevance of heightened LAT expression in DNAM+ NK cells was shown for calcium flux, 
IFN-γ production and degranulation triggered via NK1.1 crosslinking. In agreement with our study, 
experiments on human NK cells demonstrated that higher responsiveness of DNAM-1+ NK cells 
was also applied for target cells that do not express DNAM-1 ligand, including 721.221 and 
Drosophila S2 cells transfected with CD48 and ULBP1 [60]. The inside-out signal from DNAM-
1 via LFA-1 conformation was suggested to be crucial for the immunological synapse formation 
towards the target cells and hence cytotoxic functions of NK cells [60]. Our study added another 
explanation, LAT-1 expression, for the heightened responsiveness of DNAM-1+ NK cells.  
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Figure 8. DNAM-1/CD155 and IL-15 
cooperate to induce LAT expression. 
DNAM-1+ NK cells are more responsive 
to IL-15 stimulation with regards to LAT 
expression. The absence of DNAM-1 
interaction with CD155 compromises 
LAT expression. The increased level of 
LAT expression in DNAM-1+ NK cells 
endowed them with higher capacity to 
response to activating receptor NK1.1, as 
measured by calcium flux, IFN-γ 
production, and degranulation.  
In this study, we provided evidence showing that DC-derived IL-15 regulates LAT expression in 
NK cells via a transcriptional regulation. Upon 10 days of DC depletion, we found that ELF1, a 
member of ETS family of transcription factors, was significantly downregulated at the protein level 
in NK cells. In addition, adding back WT DC to DC-depleted mice restored the ELF-1 expression 
in NK cells to a similar level from non-DC depleted mice. The LAT promotor possesses two 
bindings sites for ETS transcription factor family and point mutations in these sites reduced LAT 
expression in Jurkat cells [229]. Antibody supershift experiments focusing on only four members 
of ETS family out of 16 members that are expressed in Jurkat cells, demonstrated that ELF1 and 
possibly also ETS1 bind to the LAT promotor [229]. It would be interesting to address why ELF-
1 is particularly increased in DNAM-1+ NK cells upon IL-15 stimulation. Is it a direct effect of 
DNAM-1 signaling? DNAM-1 stimulation experiments would provide an explanation.  
We have showed that the expression of DNAM-1 endowed NK cells with heightened 
responsiveness towards NK1.1 triggering in regards to IFN-γ, degranulation, and calcium flux. 
DNAM-1 has been demonstrated to be a marker for NK cell education in both mice and human. 
The fractions of cells expressing DNAM-1 is higher in educated subsets as compared to uneducated 
subsets [52, 60]. An obvious question arising was whether the superior responsiveness of DNAM-
1+ over DNAM-1- NK cells was solely due to the education effect. In order to answer this question, 
we studied the reactivity of NK cells that are positive or negative for DNAM-1 from WT and MHC-
I KO mice. In response to NK1.1 crosslinking, DNAM-1+ NK cells from MHC-I KO showed a 
higher level of IFN-γ production and degranulation as compared to DNAM-1- counterparts. This 
demonstrated that the better responsiveness towards NK1.1 stimulation of DNAM-1+ NK cells as 
compared to DNAM-1- cells was not accounted by the education effects.  
In the same paper, paper II, we have demonstrated that the superior responsiveness of the DNAM-
1+ subset over DNAM-1- cells was owning to the direct interaction between DNAM-1 and its main 
ligand in mice, CD155. We showed that LAT expression is lowered in NK cells from CD155 and 
DNAM-1 KO mice as compared to those from WT mice. Nevertheless, our data was not in line 
with a study by Martinet and co-workers, in which interaction between CD155 and DNAM-1 was 
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claimed to not be important for the functional differences between DNAM-1+ and DNAM-1- 
subsets [61]. However, in this paper, only cytokine production, including IFN-γ, IL-6 and MIP-1α 
in response to IL-12 plus IL-18 stimulation was evaluated. In addition, the absence of DNAM-1 
expression in DNAM-1 KO mice did not render NK cells hyporesponsive, even though they 
displayed significantly lowered missing-self reactivity as compared to WT NK cells [52]. It is likely 
that DNAM-1+ and DNAM-1- subsets possess a different potency towards different stimuli and that 
might depend on whether LAT is crucial in this certain stimulation. LAT and LAT2, were shown 
to play differential roles in IL-2 activated versus resting NK cells, in which the ZAP70-LAT 
pathway is more crucial in IL-2 activated NK cells while resting cells require SYK-LAT/LAT2 for 
an optimal responsiveness [230]. Further studies to explore the roles of LAT and LAT2, in DNAM-
1+ and DNAM-1- subsets will shed light on the developmental requirement of adaptor molecules. 
With regard to the cell type providing CD155 signal to NK cells, CD11c+MHC-IIhigh DCs from 
peripheral LNs express CD155 at the highest level as compared to other immune cell types analyzed 
from spleen, thymus, and LNs [231]. The frequent contacts between NK and DCs might be the 
results of their close proximity in the niche, or due to the DNAM-1-CD155 interaction, and hence 
allowing a higher responsiveness to IL-15 signals. Future experiments to study localization and 
movement of NK cells and DCs in the LNs in the presence or absence of DNAM-1-CD155 
interaction will address this question.  
 IL-15 versus IL-2 in NK cell development and functions  
The differences between IL-15 and IL-2 are interesting in relation to NK cell development and 
functions. Even though, IL-2 was not the focus of the thesis, I am captivated by the fact that IL-15 
is indispensable for NK cell development while IL-2 is not. The question is intriguing while 
considering the fact that IL-15 and IL-2 stimulations lead to activation of exactly the same signaling 
pathways [232]. The same signaling is induced despite that IL-15 and IL-2 act on different α chains 
of the receptor complexes while sharing β and γc components. The differential roles of IL-15 and 
IL-2 in NK cell development could be attributed to cellular distribution of their cognate alpha-
receptors and the modes of delivery. IL-2 seems to exert effects more efficiently in cis-presentation 
while IL-15 requires trans-presentation, due to differential affinity to their cognate receptor α chains 
(IL-2 and IL-2Rα: Kd = 10 nM, IL-15 and IL-15Rα: Kd = 50 pM) [124, 221]. In fact, NK cells and 
their progenitors do not highly express IL-2Rα at the steady-state. On the other hand, accessory 
cells, including DCs, macrophages, and stromal cells, are readily present in the bone marrow niche 
to trans-present IL-15 to NK cells through their IL-15Rα [233]. Of note, NK cell development in 
vitro can be induced by high amounts of IL-2 triggered via IL-2Rα lowly expressed in cis on NKP 
[234]. However, IL-2 is produced by activated cells, including T and NK cells, which are not readily 
present in the BM niche [235]. On mature NK cells, IL-2Rα is significantly upregulated upon 
activation and hence contributes to the functional priming and the survival support via the 
augmentation of the expression of perforin, granzyme B, and survival factors like BCL-2 or MCL-
1. Hence, both IL-15 and IL-2 are crucial for homeostasis and functional responsiveness of mature 
NK cells [142, 236, 237], while only IL-15 is indispensable for NK cell development. 
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 FOXO CONTROL NK CELL DEVELOPMENT AND MATURATION 
The FOXO family of transcription factors plays such a diverse role in controlling immune cell 
homeostasis, differentiation, homing, memory formation, and effector functions [182]. FOXO1 KO 
mice are embryonically lethal due to the incomplete vascular development and FOXO3 KO female 
mice are infertile because of the abnormal ovarian follicle development [238]. Therefore, specific 
deletion of FOXOs is necessary to study their contributions to biology of certain immune cells. In 
paper IV, we made used of two mouse models that lack FOXO1,3 depleted in early hematopoietic 
cells or in committed NK cells. In the first model, Ncr1+iCre FOXO1,3flox/flox (denoted as 
FOXO1,3DNcr1), the Cre recombinase is expressed under the control of the Ncr1 promotor, the same 
mouse line that was used in Deng et al. [136], therefore, FOXO1,3 are depleted in committed NK 
cells that express Ncr1 (NKp46). Furthermore, in order to explore the roles of FOXO1,3 in early 
NK cell linage specification, we made mouse strains with the specific depletion of FOXO1, 
FOXO3, or both in Vav1+ cells by crossing Vav1+Cre with FOXO1,3flox/flox mice. The resulting 
strains are named in this thesis as FOXO1DVav1, FOXO3DVav1 and FOXO1,3DVav1 [183]. The study 
with mice expressing lacZ reporter only in Vav1+ cells demonstrated that Vav1 expression in vivo 
was restricted to hematopoietic and endothelial cells [199]. Due to the expression of Vav1 in the 
endothelial cells and the functions of FOXO3 for ovarian follicle development, the females which 
were used for breedings were iCre-/-FOXO1,3flox/flox, therefore preventing the deletion of FOXO3 
in the ovary and infertility.  
 FOXO1,3 control NK cell development 
Using the Ncr1+iCre mouse model [239], we confirmed the findings by Deng et al. that deleting 
FOXO1 and FOXO3 does not compromise NK cell development, with normal NK cell 
compartments in both BM and spleen. On the other hand, FOXO1,3 depletion in early 
hematopoietic cells (Vav1+) causes a block in NK cell development at the preNKP stage and a 
severe reduction in BM and splenic NK cells (Figure 9). The few NK cells that develop in the 
absence of FOXO1,3 display an immature phenotype and perturbed expression of activating and 
inhibitory receptors. The effects of FOXO1,3 on the development and phenotype of NK cells are 
intrinsic as demonstrated by the transplantation experiments. Based on RNA seq and ATAC seq 
data, we suggest that FOXO1,3 coordinate to control expression and/or DNA binding of TCF7, 
ETS1 and CD122.  
FOXO1,3 were showed to control the expression of proteins involved in cell homing, including L-
selectin (CD62L) and sphingosine-1-phosphate receptor 1 (S1pr1) [136, 186, 240]. In line with 
these studies, we found that S1pr1 significantly down-regulated (8 folds) in preNKP of 
FOXO1,3DVav1 mice as compared to controls. In addition, FOXO1,3 depletion compromised the 
survival of committed NK cells (NK1.1+CD3-) in both BM and spleen. This might be due to the 
defective autophagy and heightened ROS level as reported by Deng et al. [198]. Or the lower 
expression of CD122 might render NK cells less responsive to IL-15 in both BM and spleen. In 
fact, we believe that the dramatic effect on the NK cell population in the spleen of FOXO1,3DVav1 
mice could be the combined result of the lower egress from BM and the lower survival of NK cells 
in general.  
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Figure 9. Deletion of FOXO1,3 in Vav1+ cells compromised NK cell development. Vav1 is 
expressed early in hematopoietic cells hence NK cell development from CLP can be studied in 
Vav1+iCre FOXO1,3flox/flox mouse model. The results of FOXO1,3 depletion in Vav1+ cells are indicated 
in red arrows and letters. FOXO1,3 depletion led to a decreased transition from preNKP to rNKP. The 
reduction in expression and/or DNA binding of ETS1, TCF7 and CD122 might account for the 
developmental block. Furthermore, committed NK cells developing in the absence of FOXO1,3 show 
higher apoptosis and less mature phenotype. On the other hand, in our study and from [136], depletion 
of FOXO1,3 in Ncr1+ cells in the Ncr1+iCre FOXO1,3flox/flox mouse model did not compromise NK cell 
development and numbers but resulted in an accelerated maturation process due to an increased T-BET 
expression. The results of FOXO1,3 depletion in Ncr1+ cells are indicated in blue arrow and letters. 
FOXO1,3 regulate NK cell development in a hematopoietic intrinsic mechanism. In an attempt to 
address this question, we transplanted enriched BM cells from WT or FOXO1,3DVav1 mice to 
irradiated recipient mice. Congenic markers were used to distinguish between donor and recipient 
cells (CD45.1 versus CD45.2). FOXO proteins were shown to support the long-term repopulating 
capacity of hematopoietic stem cells (HSCs) as their absence increased cell cycling and apoptosis 
rate of these cells [241]. Therefore, in the transplantation experiments, FOXO proteins were crucial 
for an efficient long-term reconstitution of donor BM cells [242]. We have encountered the 
apparent challenge which is the poor reconstitution of FOXO1,3DVav1 BM cells despite being at a 
much higher number at the start as compared to WT cells (three million FOXO1,3DVav1 cells as 
compared to 0.2 million WT cells). In order to overcome this problem, we injected a group of mice 
with three million CD45.2+ FOXO1,3DVav1 cells together with 0.2 million CD45.1+ WT cells as 
support cells. Despite being surrounded by WT support cells, FOXO1,3DVav1 BM progenitor cells 
still failed to develop to NK cells, suggesting that the requirement of having FOXO1,3 for NK cell 
development was intrinsic. Taken together, HSCs and NKP require FOXO1,3 expression by 
themselves in order to develop to NK cells.  
 FOXO1,3 control NK cell maturation  
Using the Vav1+iCre FOXO1,3floxed/floxed mouse model, we also studied the impact of FOXO1,3 
deletion on NK cell maturation and receptor expression. Consistent with Deng et al., NK cells from 
FOXO1DVav1 mice were more mature as compared to WT controls with an increased 
CD27lowCD11bhigh population. However, different from Deng et al., NK cell maturation from 
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FOXO1,3DVav1 was perturbed but not in the same pattern as FOXO1DVav1. NK cells from 
FOXO1,3DVav1 are less mature with an accumulation of the immature subsets, CD27lowCD11blow 
and CD27highCD11blow and a smaller fraction of the mature subset, CD27lowCD11bhigh. This finding 
points to the temporal effect of FOXO1,3 in modulation NK cell maturation, likely via T-BET 
expression. If FOXO3 is deleted early in Vav1+ hematopoietic cells, its role in positively controlling 
T-BET expression counteracts FOXO1-mediated-inhibition of T-BET expression. While, FOXO3 
deletion in Ncr1+ committed NK cells fails to counteract the effect of FOXO1 deletion, as 
FOXO1,3DNcr1 NK cells and FOXO1DNcr1 are comparably mature [136]. FOXO have been known 
to decide cell fates by integrating external and internal signals. FOXO proteins are controlled by 
and modulate multiple cellular pathways. Therefore, our study suggests that the temporal difference 
in FOXO deletion might have resulted from the perturbation in different cellular pathways.  
In an attempt to decipher the network of transcription factors involving FOXO1,3 that controls NK 
cell maturation, we examined the expression of EOMES and T-BET in BM immature NK cells 
from FOXO1,3DVav1 and WT mice. EOMES expression in CD11blow BM NK cells from 
FOXO1,3DVav1 mice was significantly lowered as compared to those from WT controls, while T-
BET expression showed a trend in reduction. EOMES has been shown to be important for NK cell 
maturation due to its controlling CD122 expression [243]. NK cells from Eomesflox/floxVav1+iCre 
mice also displayed an immature phenotype with the accumulation of CD27highCD11blow subset, 
which is similar to EOMES negative NK cells from WT mice [243]. FOXO1 has been shown to 
bind indirectly to the promotor of Eomes [244] and FOXO3 binds to both the promotor and 
enhancer regions of Eomes [245]. Another explanation to account for the reduced maturation of 
NK cells in FOXO1,3DVav1 is the lower responsiveness to IL-15 signal due to the lower CD122 
expression. It was shown that the few NK cells that develop in spleens of Rag2 KO IL-15 KO nice 
were less mature with a lower CD43+CD11b+ fraction [91]. Taken together, the deletion of 
FOXO1,3 in Vav1+ progenitor cells led to different changes in NK cell maturation as compared to 
their deletion in Ncr1+ committed NK cells. 
 FOXO1,3 in the network with other transcription factors that modulates 
IL-15 signaling  
FOXO1 is located mostly in the nucleus of NKP while it resides preferentially in the cytosol of 
iNK and mNK [198]. This suggests potential transcriptional importance of FOXO1 in NKP, e.g. 
transcriptional control of IL7-Rα and ETS1. FOXO protiens control expression of numerous 
transcription factors and also interact with co-factors to induce or suppress gene expression [176, 
246]. Motif analyses of target genes in both mice and Caenorhabditis elegans showed that many 
co-activators or co-suppressors might coordinate with FOXO proteins to control target gene 
expression. In mouse, the co-activators and co-suppressors belong to Forkhead, ETS, CTCF, 
bHLH, and CTF families [246]. In NK cells, it has been shown that FOXO1 is recruited to T-BET 
promoter via Sp1, to inhibit T-BET expression [136]. In our study, by RNA-seq and ATAC-seq, 
we uncovered a potential molecular mechanism underlying FOXO1,3-mediated NK cell 
development. RNA-seq was used to study the global transcriptional program while ATAC-seq is a 
useful tool to investigate the chromatin landscape.  
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ATAC-seq is a recently developed method to for epigenomic profiling that provides information 
regarding to DNA accessibility, regions of transcription factor bindings as well as nucleosome 
position [247, 248]. ATAC-seq is superior over older methods regarding to the low amount of 
starting material, the simple and short-time sample preparation, and the interrogation of different 
epigenetic information [248]. ATAC-seq makes use of hyperactive Tn5 transposase to 
simultaneously cut and ligate high-throughput sequencing adaptors to regions of good accessibility. 
Regions of transcription factor binding can be identified based on a sudden decrease of reads within 
a peak, called “footprint” [268]. ATAC-seq together with RNA-seq experiments demonstrated that 
ETS1 expression and footprints were reduced in FOXO1,3DVav1 CLP as compared to littermate 
controls.  
In addition to ETS1, RNA seq experiment on preNKP showed that expression of TCF7 was also 
down-regulated from FOXO1,3DVav1 mice as compared to WT mice. TCF7 was shown to contribute 
to early NK cell development as TCF7 depletion compromised the formation of NKP in a similar 
way as ETS1 KO and FOXO1,3DVav1 mice [78, 83, 249]. As opposed to the reduced expression in 
preNKP, TCF7 expression was significantly increased in CLP from FOXO1,3DVav1 mice. 
Nevertheless, we found a reduction of 46 TCF7 footprints on DNA, which hints to its lower activity, 
in CLP from FOXO1,3DVav1 mice. CLP and preNKP might possess different levels of co-activators 
or co-repressors, leading to differences in TCF7 expression changes upon FOXO1,3 depletion. 
Different from ETS1 and TCF7, NFIL3 did not exhibit changes in either expression or DNA 
binding capacity upon depletion of FOXO1,3 in both CLP and preNKP.  
ETS1 has been shown to bind to the CD122 promotor and control its expression [83]. When CD122 
is expressed at a very low level due to FOXO1,3 depletion, the rNKP population cannot be formed. 
FOXO1,3DVav1, IL-15KO Rag2 KO and IL-15Rα KO mice [91] are similar with regards to NK cell 
progenitor development and maturation. Indeed, we found a similar reduction in NKP population 
from IL-15Rα KO mice (data not shown). We found a reduced EOMES expression in CD11blow 
NK cells from BM in FOXO1,3DVav1 mice, which might be the contributing factor for the lower 
CD122 expression as EOMES was shown to positively regulate CD22 expression [243]. As further 
confirmation of the reduction in IL-15 responsiveness, we showed that the fraction of splenic NK 
cells undergoing apoptosis was significantly increased in the absence of FOXO1,3. These findings 
suggest a network of transcription factors, including FOXO1,3, ETS1 and TCF7, modulates CD122 
expression and hence NK cell development, survival and maturation.  
The differences in NK cell development and maturation between depletion of FOX1,3 in early NKP 
(Vav1+) and committed NK cells (Ncr1+) are interesting. We found that NK cell development was 
compromised in FOXO1,3DVav1 mice while largely spared in FOXO1,3DNcr1 mice. We suggested 
that the developmental defect was due to the lower CD122 expression and hence the lower IL-15 
responsiveness. FOXO1,3 might also control CD122 expression in committed NK cells. However, 
the phenotype might be minute due to the positive feedback loop of IL-15 signaling, that once 
CD122 is expressed, its expression is sustained. A positive feedback loop was found to mediate 
PDK-mTOR-EOMES-NFIL3-CD122 pathway, supporting the sustained expression of IL-15R and 
IL-15 signaling [81]. Besides, NK cell maturation from FOXO1,3DVav1 and FOXO1,3DNcr1 mice is 
also not similar, with an accelerated maturation in FOXO1,3DNcr1 mice while a decreased maturation 
 36 
in FOXO1,3DVav1 mice. The difference can be accounted to the differences in T-BET and EOMES 
expression when FOXO1,3 are depleted in NKP or committed NK cells. When FOXO1,3 were 
depleted in committed NK cells, T-BET expression was increased and hence a higher proportion 
of mature NK cells was formed. However, when FOXO1,3 were depleted in NKP, T-BET and 
EOMES expression was significantly reduced. This difference might again be due to different 
networks of transcription factors present in NKP versus NK cells. So far, we have not found the 
possible underlying molecular mechanism accounting for the lower T-BET expression when 
FOXO1,3 were depleted in NKP. ChIP sequencing of FOXO binding regions will reveal any 
differences in the transcriptional network controlled by FOXO1 and FOXO3 in NKP and NK cells. 
 FOXO1,3 control ILC development 
NK cells were recently placed together with ILC1 in group 1 ILC. Observing a severe defect in NK 
cell development on FOXO1,3DVav1 mice, we asked whether the depletion of FOXO1,3 also 
affected ILC lineage specification. This is an apparent question since the preNKP and the rNKP 
populations indeed do share phenotypic characteristics with ILCP in the expression of GATA3, 
ZBTB16, α4β7 and CD122 expression [89]. In study IV, we showed that the ILC1 population was 
significantly reduced in BM while ILC3 was decreased in BM and thymus while increased in the 
spleen. On the other hand, the ILC2 population, especially ST2- ILC2 displayed an expansion in all 
three organs. The reduction in ILC1 is in line with the defect in NK cell development as both ILC1 
and NK cells rely on IL-15 for their development. The ILC3 population is dependent on the 
transcription factor RORC and we revealed that RORC is downregulated in both preNKP/ILCP 
and committed ILC3, as showed by RNA-seq and flow cytometry data. We also showed a reduction 
in IL23r expression in preNKP/ILCP population in FOXO1,3DVav1 as compared to WT mice. The 
ILC2 and ILC3 require IL-7 for their development and the reduction in ILC3 might have led to an 
increase in ILC2 population. In addition, the expansion of ILC2 population might not be solely the 
indirect effect of the IL-7 niche. Indeed, FOXO expression or activity were linked with ZBTB16 
and BCL11B [250-252], two indispensable transcription factors for ILC2 formation [97]. Taken 
together, in paper IV, we have shown that FOXO1,3 are crucial for NK cell and ILC development.  
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3 CONCLUSION AND OUTLOOK 
IL-15 is a crucial factor orchestrating the entire life of an NK cell, including development, 
proliferation, survival, and activation (Figure 1) [91]. IL-15 exerts its effect mostly via trans-
presentation mediated by the IL-15Rα expressed on accessory cells, including DCs. Upon brief 
contacts in the LNs, NK cells receive signals from DCs at the steady-state. IL-15 deficiency in mice 
results in a block in NK cell development. Likewise, mice with low expression of various 
transcription factors, or signaling molecules that act downstream of IL-15 signaling, including 
JAK3, STAT5, AKT and mTOR, also exhibited defective NK cell development. This thesis has 
addressed several aspects of IL-15 in murine NK cell biology, including i) the discovery of new 
transcription factors which regulate IL-15R expression, and hence, are crucial for NK cell 
development, ii) the exploration of functional effects of the short-time priming, iii) the study of the 
crosstalk between DNAM-1 and IL-15 signaling, and iv) the investigation of how homeostasis and 
functions of NK cells are controlled by DCs in vivo.  
In paper I, we investigated changes in homeostasis and functions of NK cells upon conditional 
depletion of DCs. Making use of a mouse model in which DTR is expressed under the control of 
the CD11c promotor, we could specifically deplete DCs in the spleen under non-inflammatory 
conditions. In the absence of DCs, NK cells were less mature and expressed fewer inhibitory 
receptors and their in vivo missing-self reactivity was compromised. Gene array and flow cytometry 
analyses demonstrated a defect in IL-15 signaling in NK cells upon DC depletion. Our data 
demonstrated that, like T cells, NK cells require a tonic signal from accessory cells at the steady-
state for their optimal homeostasis and functions.  
Paper II explored the same system as in paper I and elaborated on the molecular consequences of 
DC interactions with NK cells. We demonstrated in this study that both DNAM-1 and IL-15 signals 
increased expression of the LAT protein, a key player in the transmission of activating signals in 
NK cells. Therefore, NK cells might receive various signals from DCs in the LNs, including among 
others IL-15, IL-12, IL-18, DNAM-1, MHC-I, to gain optimal functions and to be ready for fighting 
infections.  
In paper III, we studied the outcomes of the brief stimulation of NK cells by IL-15, artificially 
mimicking what might take place when IL-5 is presented in short contacts with accessory cells in 
vivo. This work revealed that short-time contacts with IL-15 left remarkably robust signaling 
imprints and functional impacts on NK cells, including IFN-γ production, degranulation, and 
cytotoxicity. In addition, IL-15 stimulation increased phosphorylation of proximal signaling 
molecules downstream of activating receptors, providing a mechanistic link to the increased 
functional capacity. Furthermore, the short-time priming effects were long-lasting, indicating its 
possible physiological relevance. Albeit speculative, and open to further experimentation, it could 
be hypothesized from our data that the short-term interactions between DCs and NK cells that have 
been described in vivo, could, despite short contacts, result in an enhanced functional imprint that 
would be sufficiently long-lasting to allow migration to peripheral tissues and execution of effector 
functions against NK cell targets. 
Paper IV takes a step back from the functionally oriented studies of the other papers and focuses 
on NK cell development in the bone marrow, specifically on the role of a set of transcription factors 
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for this process. FOXO1,3 depletion in hematopoietic progenitors resulted in a block in NK cell 
development with a significant decrease in rNKP and NK cell populations in both BM and spleen. 
In parallel with the compromised NK cell development, ILC development was also perturbed, with 
a tendency in an increase in ILC2 and a decrease in ILC1 and ILC3 populations. Mechanistically, 
RNA-seq and ATAC-seq data demonstrated a lower expression and DNA binding of ETS1. 
Furthermore, IL-15 responsiveness of NK cells was reduced, which could be explained by the lower 
level of IL-15Rβ expression upon FOXO1,3 depletion. Taken together, paper IV, demonstrated a 
crucial role of FOXO1,3 in NK cell development, owing to their direct or indirect regulation of IL-
15R expression.  
It is always difficult to predict the clinical importance of findings from the basic medical science, 
which does not directly aim to novel drugs or therapeutic implications. Nevertheless, aspects of the 
work in my thesis may be directly relevant for clinical medicine, or at least suggest new studies 
with a more clinical focus. Since FOXO transcription factors play a diverse role in controlling the 
immune system, therapeutic drugs targeting FOXOs are being developed against inflammatory 
diseases. Development of chemical inhibitors against transcription factors is still challenging due 
to the overlapping specificity within members of the same family [253]. Library screening has 
gained some advances in the search for inhibitors that inhibit FOXO phosphorylation [254-256]. 
Blocking FOXO, however, has to be taken cautiously as FOXO in mice were considered as tumor 
suppressors [183].  
One challenge in NK cell therapy against leukemia has been to make NK cell proliferate, persist 
and maintain functional competence in vivo after adoptive transfer. Here, my findings on how NK 
cells respond to IL-15, in particular the mechanism regulating NK cell priming and functions after 
short-term IL-15 treatment, may suggest novel ways how to enhance these properties in patients. 
In addition, my studies on mechanisms resulting from NK cell/DC interactions in vivo may point 
to new ways in which these interactions could be enhanced. Thus, because IL-15 plays such an 
important role in supporting NK cell development and function, it has therapeutic potential to boost 
NK cell expansion and functions in vivo. Short half-life and poor bioavailability of IL-15 requires 
a development of modified IL-15 that is more stable, more readily accesses the tumor sites and has 
a higher affinity to its receptor.  
While many novel insights have been provided by my work in this thesis, much remains to be 
discovered. Regarding the role of IL-15 in development, a key question is which cell type(s) among 
hematopoietic cells provide IL-15 for NK cell development in the BM? What do contacts between 
NK cells and IL-15 trans-presenting cells look like in the LNs, not only involving DCs but also 
macrophages, monocytes, endothelial cells etc.? Furthermore, does IL-15 coordinate with 
activating receptor signaling, e.g. DNAM-1, and MHC-I/inhibitory receptor signaling to endow 
NK cells with functional responsiveness against “missing self” targets? How does NK cell 
education link to NK cell development? Do the same cell types, or cellular interactions, control 
these two processes simultaneously or are they completely different processes? Which cell types 
provide MHC-I signal for NK cell education? What is the role of IL-15 in this process, and which 
signals downstream of MHC-I receptors regulate the acquisition of effector functions in NK cells? 
Finally, the exact role for FOXO1,3 in NK cell development needs to be determined, which might 
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give novel insights into the full maturation process of these cells and potentially lead to novel ways 
to boost NK cell development in stem cell transplantation. 
Science has a start but no end. The more we discover, the more we realize that remains hidden. In 
fact, my notebook contains many more questions now compared to before my thesis work, which 
is a good sign that leaves plenty of interesting new projects for me to explore in the future. 
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